DirectorsTalk Interviews LSE London Stock Exchange PLC Company Interviews
AstraZeneca plc (LON:AZN) today announced that it has agreed to buy a US Food and Drug Administration Priority Review Voucher for a total cash consideration of $95m from a subsidiary ...
Read Article »FTSE 100
-
NMC Health PLC Strong performance for H1 2019 in core markets of UAE
-
GlaxoSmithKline PLC ViiV results positive for every 2 month injection
-
NMC Health Plc Share buyback programme
-
Antofagasta PLC Deliver robust financial results for H1
-
AstraZeneca PLC Roxadustat approved in China for the treatment of anaemia
-
AstraZeneca PLC Update on the Phase III NEPTUNE trial
-
BHP Group Results Presentation Year Ended 30 June 2019
-
Persimmon Plc in a strong position for the second half
-
AstraZeneca PLC Farxiga met primary endpoint in landmark Phase III
-
AstraZeneca plc appoints Michel Demaré to its Board of Directors
-
United Utilities Group PLC Dr John McAdam moves to ConvaTec Group Plc
-
Standard Life Aberdeen plc Share Repurchase Programme
-
Anglo American plc Share Buyback
-
The Berkeley Group Holdings plc Dividend Update
-
Admiral Group plc Results for the six months ended 30 June 2019
-
Anglo American PLC Share buyback update
-
AstraZeneca plc Calquence granted US Breakthrough Therapy Designation
-
AstraZeneca plc Lynparza Phase III PAOLA-1 trial met primary endpoint
-
Standard Life Aberdeen plc Sale of shares in HDFC Life Insurance
-
TUI AG Q3 Results
-
Micro Focus International plc Share Buyback programme
-
SSE statement on discussions relating to possible sale of SSE Energy Services
-
Anglo American PLC Share Buyback
-
WPP PLC First half on track
-
CRH returns a further €350 million of cash to shareholders
-
AstraZeneca PLC Tagrisso significantly improves overall survival
-
WPP appoints Jasmine Whitbread to the Board
-
Hargreaves Lansdown PLC Record 1,224,000 clients & AUA of £100 billion
-
EVRAZ pplc announces unaudited interim financial results for H1 2019
-
Coca-Cola HBC AG Solid results; Full Year expectations unchanged
-
Glencore PLC A challenging economic backdrop – Adjusted EBITDA declined 32% to $5.6 billion
-
Spirax-Sarco Engineering PLC Strong first half organic growth; full year expectations unchanged
-
Legal & General Group Plc Operating profit up 11% to £1 billion & LGIM net flows of £60 billion
-
Phoenix Group Holdings Expects to be in upper end of target
-
AstraZeneca PLC Lynparza Phase III PROfound trial in HRR
-
Standard Life Aberdeen PLC Well placed to deliver value & sustainable returns for shareholders
-
InterContinental Hotels Group PLC
-
Anglo American plc Share buyback
-
Rolls-Royce Holdings Good revenue progress with a significant improvement in cash for H2
-
HSBC Holdings PLC Group CEO John Flint Steps Down